Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
35.59
-1.64 (-4.41%)
At close: Jun 5, 2026, 4:00 PM EDT
36.30
+0.71 (1.99%)
After-hours: Jun 5, 2026, 7:23 PM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.83 billion as of June 5, 2026. Its market cap has increased by 149.48% in one year.
Market Cap
3.83B
Enterprise Value
3.33B
1-Year Change
149.48%
Ranking
Category
Stock Price
$35.59
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.83B, an increase of 403.14%. That is a compound annual growth rate of 36.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 3.83B | 45.76% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 4.40B |
| Celcuity | 4.31B |
| Travere Therapeutics | 4.26B |
| Veradermics | 3.83B |
| Catalyst Pharmaceuticals | 3.83B |
| Erasca | 3.72B |
| ACADIA Pharmaceuticals | 3.69B |
| NewAmsterdam Pharma Company | 3.68B |